Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Quinine sulfate cost?Atrovent generic name?Lumakras mechanism of action?Glycopyrrolate mechanism of action?How do higher lipitor doses impact side effects?
See the DrugPatentWatch profile for lumakras
Availability and Cost of Lumakras Tablets Lumakras tablets, known generically as sotorasib, are a relatively new cancer treatment medication. They are primarily developed by Amgen Inc. in collaboration with Mirati Therapeutics. Regulatory Status in India In India, Lumakras tablets are approved for the treatment of non-small cell lung cancer (NSCLC) with a specific mutation. According to an update on DrugPatentWatch.com [1], the current regulatory status for sotorasib in India is approved. Importing Medications from India Indian pharmaceutical companies manufacture and supply various generic medications. However, importing medications directly from India might be challenging without a prescription and in compliance with local laws. Consult with a healthcare professional to discuss your treatment options. Online Availability and Prices As of our knowledge cutoff date (01Dec2023), some online pharmacies in India list Lumakras tablets for sale. However, be cautious of websites that do not require a prescription, as this can be a red flag for counterfeit products. It's crucial to consult with your doctor or a licensed pharmacist to ensure you're buying from a reputable source. Comparison with Local Brands Consult with a healthcare professional to determine the suitability of Lumakras tablets or local alternatives for your specific medical needs. When Does Patent Expiration Occur? According to DrugPatentWatch.com [1], the patent for sotorasib is set to expire as early as 2025. References [1] DrugPatentWatch.com. (n.d.). Sotorasib Patent Expiration Date. Retrieved from https://www.drugpatentwatch.com/drug/sotorasib/ Please note that the above information is subject to change. Always consult a healthcare professional for personalized advice on medication and treatment options. Sources: [1] DrugPatentWatch.com.
Other Questions About Lumakras :